This HTML5 document contains 53 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
dbohttp://dbpedia.org/ontology/
foafhttp://xmlns.com/foaf/0.1/
n12https://global.dbpedia.org/id/
dbthttp://dbpedia.org/resource/Template:
rdfshttp://www.w3.org/2000/01/rdf-schema#
n8http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n17http://www.levoltapharma.com/pipeline/
owlhttp://www.w3.org/2002/07/owl#
wikipedia-enhttp://en.wikipedia.org/wiki/
dbphttp://dbpedia.org/property/
dbchttp://dbpedia.org/resource/Category:
provhttp://www.w3.org/ns/prov#
xsdhhttp://www.w3.org/2001/XMLSchema#
wikidatahttp://www.wikidata.org/entity/
dbrhttp://dbpedia.org/resource/
n16https://adisinsight.springer.com/drugs/

Statements

Subject Item
dbr:VOLT-02
rdf:type
n8:ChemicalObject dbo:ChemicalSubstance owl:Thing dbo:Drug wikidata:Q8386
rdfs:label
VOLT-02
rdfs:comment
VOLT-02 is a water-soluble conjugate of progesterone and a neurosteroid which is under development by Levolta Pharmaceuticals (formerly Voltarra Pharmaceuticals) for the treatment of traumatic brain injury, gynecological disorders, and menstrual disorders. As of March 2017, it is in phase II clinical trials for these indications. The chemical structure of VOLT-02 does not appear to have been released yet.
dcterms:subject
dbc:Neurosteroids dbc:Progestogens dbc:Pregnanes dbc:Neuroprotective_agents dbc:Experimental_drugs dbc:Drugs_with_undisclosed_chemical_structures
dbo:wikiPageID
57017072
dbo:wikiPageRevisionID
1042306239
dbo:wikiPageWikiLink
dbr:Water-soluble dbc:Neuroprotective_agents dbr:Clinical_trial dbc:Progestogens dbc:Pregnanes dbc:Neurosteroids dbr:Phases_of_clinical_research dbr:Progesterone_(medication) dbr:Menstrual_disorder dbc:Experimental_drugs dbr:List_of_progestogen_esters dbr:List_of_investigational_sex-hormonal_agents dbr:Conjugate_(biochemistry) dbr:List_of_neurosteroids dbr:Progestogen dbr:Neurosteroid dbr:Chemical_structure dbr:Gynecological_disorder dbr:Traumatic_brain_injury dbc:Drugs_with_undisclosed_chemical_structures
dbo:wikiPageExternalLink
n16:800041522 n17:
owl:sameAs
n12:6AL8L wikidata:Q55636883
dbp:wikiPageUsesTemplate
dbt:Reflist dbt:Nervous-system-drug-stub dbt:Steroid-stub dbt:Drugbox dbt:Progesterone_receptor_modulators
dbp:class
dbr:Progestogen dbr:Neurosteroid
dbp:synonyms
Progesterone conjugate
dbo:abstract
VOLT-02 is a water-soluble conjugate of progesterone and a neurosteroid which is under development by Levolta Pharmaceuticals (formerly Voltarra Pharmaceuticals) for the treatment of traumatic brain injury, gynecological disorders, and menstrual disorders. As of March 2017, it is in phase II clinical trials for these indications. The chemical structure of VOLT-02 does not appear to have been released yet.
prov:wasDerivedFrom
wikipedia-en:VOLT-02?oldid=1042306239&ns=0
dbo:wikiPageLength
2757
dbo:class
dbr:Neurosteroid dbr:Progestogen
foaf:isPrimaryTopicOf
wikipedia-en:VOLT-02